Posts Tagged ‘2021’
2022 NCBIO Year in Review
2022 NCBIO Year in Review From the NCBIO President | Laura Gunter I look back on the past twelve months of NCBIO’s work, and what stands out most to me is how much time and effort we have put into looking forward. The year was perhaps most notable for the completion of our new strategic…
Read MoreNCBIO 2020-2021 Year in Review
NCBIO looks back on a year defined by the COVID-19 pandemic and the death of our longtime president and co-founder, Sam Taylor. The organization continued to advocate for state and federal public policies that encourage the growth of life science companies and supports the development of a strong life science workforce.
Read More2021 NCBIO Annual Meeting returns to in-person, Samulski delivers keynote
2021 NCBIO Annual Meeting returns to in-person, Samulski delivers keynote Nearly 200 people attended NCBIO’s 2021 Annual Meeting Tuesday, Oct. 5, with almost 120 choosing to be there in person and about 75 opting to participate online. Attendees heard discussions of drug pricing, the challenges of a launching a startup, federal issues affecting the…
Read MoreBIO’s fall Congressional preview
The summer calm is grinding to a halt as members of Congress have returned to D.C. for what is sure to be a busy legislative sprint that could potentially impact all sectors of the biotech industry.
Read More